2024

1. A Survey of the Union of European Neonatal and Perinatal Societies on Neonatal Respiratory Care in Neonatal Intensive Care Units

   Children, Vol. 11, Núm. 2

2. A naturalistic cohort study of first-episode schizophrenia spectrum disorder: A description of the early phase of illness in the PSYSCAN cohort

   Schizophrenia Research, Vol. 266, pp. 237-248

3. A new standardized nomenclature in neurosurgery: Criteria and quantitative and qualitative evaluation indicators of medical procedures

   Neurocirugia, Vol. 35, Núm. 2, pp. 95-112

4. A web-enabled, school-based intervention for bullying prevention (LINKlusive): a cluster randomised trial

   eClinicalMedicine, Vol. 68

5. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy: the Spanish registry

   Blood

6. Accelerating SARS-CoV-2 genomic surveillance in a routine clinical setting with nanopore sequencing

   International Journal of Medical Microbiology, Vol. 314

7. Addressing catheter lock therapy: Does heparin reduce the bioactivity of dalbavancin when together in solution during freezing?

   Enfermedades Infecciosas y Microbiologia Clinica

8. Age-Related Differences in Takotsubo Syndrome: Results From the Multicenter GEIST Registry

   Journal of the American Heart Association, Vol. 13, Núm. 4, pp. e030623

9. Are lead, cadmium and mercury risk factors for resistant hypertension?

   Journal of Trace Elements in Medicine and Biology, Vol. 84

10. Association between Asthma and Lower Levels of Physical Activity: Results of a Population-Based Case–Control Study in Spain

    Journal of Clinical Medicine, Vol. 13, Núm. 2

11. Association between neutrophil to lymphocyte ratio and inflammatory biomarkers in patients with a first episode of psychosis

    Journal of Psychiatric Research, Vol. 172, pp. 334-339

12. Atezolizumab monotherapy versus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis from a randomised, controlled, phase 3 study

    The Lancet Oncology, Vol. 25, Núm. 1, pp. 46-61

13. Atezolizumab plus chemotherapy versus placebo plus chemotherapy in untreated locally advanced or metastatic urothelial carcinoma (IMvigor130): final overall survival analysis results from a randomised, controlled, phase 3 study

    The Lancet Oncology, Vol. 25, Núm. 1, pp. 29-45

14. Biomarkers in Contrast-Induced Acute Kidney Injury: Towards A New Perspective

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

15. Bloodstream infections: trends and evolution of incidence and etiology in a 12-year period (2010–2021)

    Infectious Diseases

16. COVID-19: On the threshold of the fifth year. The situation in Spain

    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, Vol. 37, Núm. 1, pp. 17-28

17. Cancer risk with biologic and targeted synthetic DMARDs in patients with rheumatic diseases and previous malignancies: Results from the BIOBADASER register

    Seminars in Arthritis and Rheumatism, Vol. 64

18. Cannon A wave validation as a diagnostic tool in paroxysmal supraventricular tachycardias

    PACE - Pacing and Clinical Electrophysiology, Vol. 47, Núm. 3, pp. 383-391

19. Cerebral venous thrombosis

    Revista Clinica Espanola

20. Characterization of an outbreak caused by Elizabethkingia miricola using Fourier-transform infrared (FTIR) spectroscopy

    European Journal of Clinical Microbiology and Infectious Diseases, Vol. 43, Núm. 4, pp. 797-803